Last reviewed · How we verify

NCT07588711

Transcutaneous Auricular Vagus Nerve Stimulation as a Treatment for Neuropathic Pain Following Spinal Cord Injury

Not yet recruiting NA
What this trial tests

NA trial testing Active Transcutaneous Auricular Vagus Nerve Stimulation in Spinal Cord Injury in 32 participants. Not yet recruiting.

Timeline
1 October 2026
30 August 2028

Quick facts

Lead sponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
PhaseNA
StatusNot yet recruiting
Enrollment32
Start date1 October 2026
Estimated completion30 August 2028

Drugs / interventions tested

Conditions studied

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Who can join

Eligibility, any sex, with Spinal Cord Injury or Neuropathic Pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Active Transcutaneous Auricular Vagus Nerve Stimulation

Trials testing the same drug.

Other recruiting trials for Spinal Cord Injury

Currently open trials in the same condition.

Other London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07588711.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing